Nextgen Biomed Ltd (TLV: NXGN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
77.90
-2.30 (-2.87%)
Sep 12, 2024, 4:54 PM IDT

Nextgen Biomed Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
792760808
Upgrade
Market Cap Growth
-61.27%-66.19%-55.05%-24.05%936.11%-9.56%
Upgrade
Enterprise Value
772052785
Upgrade
Last Close Price
0.771.273.768.3714.401.59
Upgrade
PE Ratio
--0.65-3.17-21.82-60.22-6.33
Upgrade
PB Ratio
-3.99-9.392.222.9311.596.56
Upgrade
P/FCF Ratio
-2.70-2.07-9.87-22.71-51.39-6.70
Upgrade
P/OCF Ratio
-2.79-2.09-9.87-22.71-51.79-6.70
Upgrade
EV/EBITDA Ratio
-1.68-1.28-5.73-18.52-59.03-3.97
Upgrade
EV/EBIT Ratio
-1.67-1.28-5.72-18.49-58.98-3.97
Upgrade
EV/FCF Ratio
-2.20-1.52-7.43-19.71-50.57-4.30
Upgrade
Debt / Equity Ratio
-0.12-----
Upgrade
Debt / FCF Ratio
-0.08-----
Upgrade
Quick Ratio
0.150.114.1613.944.032.50
Upgrade
Current Ratio
0.160.194.1714.124.062.54
Upgrade
Return on Equity (ROE)
-341.38%-251.97%-52.21%-18.57%-32.29%-68.09%
Upgrade
Return on Assets (ROA)
-44.10%-43.30%-11.62%-11.10%-16.19%-30.71%
Upgrade
Return on Capital (ROIC)
-72.09%-58.20%-13.62%-12.90%-20.65%-43.57%
Upgrade
Earnings Yield
-241.18%-154.43%-31.54%-4.22%-1.63%-15.80%
Upgrade
FCF Yield
-44.99%-48.29%-10.13%-4.40%-1.95%-14.92%
Upgrade
Buyback Yield / Dilution
-3.65%-0.53%-8.67%-22.66%-12.16%-
Upgrade
Total Shareholder Return
-3.65%-0.53%-8.67%-22.66%-12.16%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.